Genfit SA (GNFT)
4.21
-0.03
(-0.71%)
USD |
NASDAQ |
Nov 22, 13:16
Genfit Price: 4.21 for Nov. 22, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 21, 2024 | 4.24 | 4.24 | 4.24 | 4.24 | 705.00 |
| Nov 20, 2024 | 4.281 | 4.31 | 4.281 | 4.31 | 1980.00 |
| Nov 19, 2024 | 4.34 | 4.37 | 4.263 | 4.263 | 3682.00 |
| Nov 18, 2024 | 4.41 | 4.43 | 4.330 | 4.37 | 2336.00 |
| Nov 15, 2024 | 4.58 | 4.59 | 4.40 | 4.50 | 5528.00 |
| Nov 14, 2024 | 4.78 | 4.787 | 4.52 | 4.535 | 21493.00 |
| Nov 13, 2024 | 5.138 | 5.21 | 5.138 | 5.21 | 1284.00 |
| Nov 12, 2024 | 5.20 | 5.212 | 5.20 | 5.212 | 2714.00 |
| Nov 11, 2024 | 5.22 | 5.35 | 5.21 | 5.23 | 3255.00 |
| Nov 08, 2024 | 5.52 | 5.52 | 5.10 | 5.23 | 15031.00 |
| Nov 07, 2024 | 5.79 | 5.81 | 5.54 | 5.71 | 2166.00 |
| Nov 06, 2024 | 5.79 | 5.79 | 5.570 | 5.596 | 4376.00 |
| Nov 05, 2024 | 5.899 | 5.899 | 5.74 | 5.79 | 1828.00 |
| Nov 04, 2024 | 5.96 | 6.030 | 5.51 | 5.76 | 20971.00 |
| Nov 01, 2024 | 5.85 | 5.90 | 5.85 | 5.88 | 4690.00 |
| Oct 31, 2024 | 5.85 | 5.85 | 5.85 | 5.85 | 0.000 |
| Oct 30, 2024 | 5.80 | 5.92 | 5.65 | 5.85 | 6561.00 |
| Oct 29, 2024 | 5.68 | 5.81 | 5.502 | 5.51 | 1625.00 |
| Oct 28, 2024 | 5.597 | 5.64 | 5.51 | 5.51 | 3236.00 |
| Oct 25, 2024 | 5.54 | 5.595 | 5.50 | 5.50 | 2873.00 |
| Oct 24, 2024 | 5.76 | 5.76 | 5.51 | 5.59 | 6444.00 |
| Oct 23, 2024 | 5.77 | 5.77 | 5.530 | 5.70 | 6784.00 |
| Oct 22, 2024 | 5.84 | 5.995 | 5.74 | 5.995 | 12198.00 |
| Oct 21, 2024 | 5.92 | 5.995 | 5.90 | 5.945 | 2169.00 |
| Oct 18, 2024 | 6.16 | 6.23 | 5.861 | 5.94 | 15300.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
2.97
Minimum
Oct 25 2023
22.00
Maximum
May 11 2020
5.430
Average
4.12
Median
Jan 24 2022
Price Benchmarks
| Edap TMS SA | 2.53 |
| DBV Technologies SA | 0.455 |
| Cellectis SA | 1.86 |
| Adaptimmune Therapeutics PLC | 0.636 |
| Akari Therapeutics PLC | 1.245 |
Price Related Metrics
| PE Ratio | 37.36 |
| PS Ratio | 3.048 |
| Price to Book Value | 2.013 |
| Earnings Yield | 2.68% |
| Market Cap | 210.11M |
| Operating PE Ratio | 19.64 |
| Normalized PE Ratio | 40.00 |